SKI Market

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

623.2817716

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

7.35

12274.31

EPS(TTM)

Face Value()

Div & Yield %

59.18

0.57

Particulars(INCOME)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)	Mar 2017 ( Cr)
Sales Turnover	8141.58	7567.93	6712.63	6304.87	5544.21	8095.50
Excise Duty	0.00	0.00	0.00	0.00	23.77	106.27
Net Sales	8141.58	7567.93	6712.63	6304.87	5520.44	7989.23
Other Income	1044.96	470.13	625.34	954.61	328.48	148.24
Stock Adjustments	16.13	-5.24	-48.77	-471.81	-139.71	83.52
Total Income	9202.67	8032.82	7289.20	6787.67	5709.21	8220.99
EXPENDITURE :
Raw Materials	3425.06	2944.53	2617.22	1887.15	1936.20	2509.01
Power & Fuel Cost	91.34	80.49	90.76	82.99	70.87	122.90
Employee Cost	1193.20	1107.40	1072.33	969.98	895.67	914.47
Other Manufacturing Expenses	347.04	267.26	230.03	218.75	218.31	249.99
Selling & Administrative Expenses	1062.89	914.37	977.77	992.83	877.92	926.57
Miscellaneous Expenses	349.97	358.30	371.53	353.89	280.76	687.62
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	6469.50	5672.35	5359.63	4505.58	4279.72	5410.56
Operating Profit	2733.18	2360.47	1929.57	2282.08	1429.48	2810.43
Interest	236.04	265.90	256.39	223.81	190.90	152.60
Gross Profit	2497.14	2094.57	1673.18	2058.27	1238.58	2657.83
Depreciation	159.70	150.82	138.54	106.28	95.93	104.93
Profit Before Tax	2337.44	1943.75	1534.64	1951.99	1142.65	2552.90
Tax	411.08	343.62	269.24	383.50	201.82	604.02
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-71.42	-49.31	-89.14	-53.61	-73.51	-191.74
Reported Net Profit	1997.79	1649.45	1354.55	1622.11	1014.35	2140.61
Extraordinary Items	354.02	59.87	14.43	277.16	-1.91	-181.39
Adjusted Net Profit	1643.77	1589.58	1340.12	1344.95	1016.26	2322.00
Adjustment below Net Profit	1.61	2.48	-5.42	-3.54	-12.16	-13.78
P & L Balance brought forward	12921.86	11340.47	10059.38	8508.84	7563.08	5492.69
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	57.30	70.54	68.03	68.03	56.43	56.43
P & L Balance carried down	14863.96	12921.86	11340.47	10059.38	8508.84	7563.08
Dividend	0.00	0.00	0.00	0.00	56.43	56.43
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	250.00	250.00	250.00	200.00	200.00	200.00
Dividend Per Share(Rs)	2.50	2.50	2.50	2.00	2.00	2.00
Earnings Per Share-Unit Curr	70.80	58.46	48.00	57.49	35.95	75.86
Earnings Per Share(Adj)-Unit Curr	70.80	58.46	48.00	57.49	35.95	75.86
Book Value-Unit Curr	593.21	524.84	468.73	423.22	368.27	334.43
Book Value(Adj)-Unit Curr	593.21	524.84	468.73	423.22	368.27	334.43

18,696.10 -116.40
(-0.62%)

62,868.50 -415.69
( -0.66%)

43,103.75 -156.90
( -0.36%)

31,052.10 -68.40
( -0.22%)

11,461.50 -20.95
(-0.18%)

34,429.88 34.87
(0.10%)

18,675.35 -61.09
(-0.33%)

27,777.90 -448.18
(-1.59%)

81.18 -0.23
(-0.29%)

84.98 0.62
(0.74%)

98.83 1.19
(1.21%)

0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

18,696.10 -116.40 (-0.62%)

62,868.50 -415.69 ( -0.66%)

43,103.75 -156.90 ( -0.36%)

31,052.10 -68.40 ( -0.22%)

11,461.50 -20.95 (-0.18%)

34,429.88 34.87 (0.10%)

18,675.35 -61.09 (-0.33%)

27,777.90 -448.18 (-1.59%)

81.18 -0.23 (-0.29%)

84.98 0.62 (0.74%)

98.83 1.19 (1.21%)

0.60 0.01 (1.60%)

EQUITY - MARKET SCREENER

18,696.10 -116.40
(-0.62%)

62,868.50 -415.69
( -0.66%)

43,103.75 -156.90
( -0.36%)

31,052.10 -68.40
( -0.22%)

11,461.50 -20.95
(-0.18%)

34,429.88 34.87
(0.10%)

18,675.35 -61.09
(-0.33%)

27,777.90 -448.18
(-1.59%)

81.18 -0.23
(-0.29%)

84.98 0.62
(0.74%)

98.83 1.19
(1.21%)

0.60 0.01
(1.60%)